Wu C - Search Results

1

Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans.

Tian C, Chen Y, Liu Y, Wang S, Li Y, Wang G, Xia J, Zhao XA, Huang R, Lu S, Wu C. Tian C, et al. Among authors: wu c. Emerg Microbes Infect. 2018 Feb 16;7(1):16. doi: 10.1038/s41426-018-0034-0. Emerg Microbes Infect. 2018. PMID: 29449582 Free PMC article.

2

Vaccination against hepatitis B: the Chinese experience.

Zhou YH, Wu C, Zhuang H. Zhou YH, et al. Among authors: wu c. Chin Med J (Engl). 2009 Jan 5;122(1):98-102. Chin Med J (Engl). 2009. PMID: 19187625 Review.

3

[Establishment of long-term culture system for human B cells derived from peripheral blood mononuclear cells activated via soluble CD40 ligand].

Wu C, Liu Y, Zhao Q, Chen GM, Chen JH, Yan XM, Zhou YH, Huang ZH. Wu C, et al. Zhonghua Yi Xue Za Zhi. 2009 Jan 13;89(2):124-7. Zhonghua Yi Xue Za Zhi. 2009. PMID: 19489277 Chinese.

4

A novel hepatitis B virus mutant coexisting with wild type virus in a carrier with negative HBsAg yet positive HBeAg and anti-HBs.

Zhou YH, Zhou J, Li L, Bi Y, Liu Y, Pan J, Wu C. Zhou YH, et al. Among authors: wu c. J Clin Virol. 2009 Dec;46(4):363-6. doi: 10.1016/j.jcv.2009.09.012. Epub 2009 Sep 25. J Clin Virol. 2009. PMID: 19782639

5

Application of truncated immunodominant polypeptide from hepatitis E virus (HEV) ORF2 in an assay to exclude nonspecific binding in detecting anti-HEV immunoglobulin M.

Pan JS, Zhang K, Zhou J, Wu C, Zhuang H, Zhou YH. Pan JS, et al. Among authors: wu c. J Clin Microbiol. 2010 Mar;48(3):779-84. doi: 10.1128/JCM.01671-09. Epub 2009 Dec 30. J Clin Microbiol. 2010. PMID: 20042615 Free PMC article.

6

Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, China.

Liu Y, Li P, Li C, Zhou J, Wu C, Zhou YH. Liu Y, et al. Among authors: wu c. Virol J. 2010 Aug 19;7:193. doi: 10.1186/1743-422X-7-193. Virol J. 2010. PMID: 20718994 Free PMC article.

7

Soluble CD40 ligand-activated human peripheral B cells as surrogated antigen presenting cells: A preliminary approach for anti-HBV immunotherapy.

Wu C, Liu Y, Zhao Q, Chen G, Chen J, Yan X, Zhou YH, Huang Z. Wu C, et al. Virol J. 2010 Dec 23;7:370. doi: 10.1186/1743-422X-7-370. Virol J. 2010. PMID: 21176236 Free PMC article.

8

[Relationship between PD-1 expression on peripheral T lymphcytes and HBeAg seroconversion after entecavir treatment in chronic hepatitis B patients].

Xia J, Xu L, Liu Y, Yan XM, Li XH, Hao YY, Cheng J, Wu C. Xia J, et al. Among authors: wu c. Zhonghua Gan Zang Bing Za Zhi. 2011 Feb;19(2):93-7. doi: 10.3760/cma.j.issn.1007-3418.2011.02.005. Zhonghua Gan Zang Bing Za Zhi. 2011. PMID: 21492509 Chinese.

9

Interferon-alpha plus adefovir combination therapy versus interferon-alpha monotherapy for chronic hepatitis B treatment: A meta-analysis.

Huang R, Hao Y, Zhang J, Wu C. Huang R, et al. Among authors: wu c. Hepatol Res. 2013 Oct;43(10):1040-51. doi: 10.1111/hepr.12058. Epub 2013 Jan 29. Hepatol Res. 2013. PMID: 23356962

10

Association between cytotoxic T-lymphocyte-associated antigen 4 +49A/G polymorphism and persistent hepatitis B virus infection in the Asian population: evidence from the current studies.

Huang R, Hao Y, Fan Y, Yang C, Wu K, Cao S, Wu C. Huang R, et al. Among authors: wu c, wu k. Genet Test Mol Biomarkers. 2013 Aug;17(8):601-6. doi: 10.1089/gtmb.2013.0069. Epub 2013 Jun 1. Genet Test Mol Biomarkers. 2013. PMID: 23725008 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,603 results

Search Page

Filters